Diagnostic Assessment and Classification of Acid–Base Disorders
Objective
Apply a systematic approach to interpret arterial blood gas (ABG) values, calculate anion gap and delta ratio, recognize compensatory limits, and use classification tools to stratify severity and guide initial management.
1. Clinical Manifestations and Initial Evaluation
Early recognition of neurologic, cardiovascular, and respiratory signs drives timely arterial blood gas (ABG) sampling and acid–base assessment.
Neurologic
- Acidemia: Manifests as a spectrum from confusion to lethargy, and ultimately to stupor or coma.
- Alkalemia: Can cause paresthesias, tetany (due to decreased ionized calcium), and hyperreflexia.
Cardiovascular
- Acidemia: Leads to decreased myocardial contractility, hypotension, and hyperkalemia, which increases the risk for arrhythmias.
- Alkalemia: Associated with hypokalemia and hypomagnesemia, which can prolong the QT interval and precipitate torsades de pointes.
Respiratory
- Metabolic acidosis: Characterized by Kussmaul respirations (deep, rapid breathing) as a compensatory mechanism.
- Respiratory acidosis: Results from hypoventilation, causing dyspnea.
- Respiratory alkalosis: Presents with tachypnea and may cause lightheadedness.
Initial Workup
A comprehensive initial evaluation includes an ABG with a basic metabolic panel (Na⁺, Cl⁻, HCO₃⁻, albumin) and a thorough history focusing on volume status, drug exposures, and underlying chronic diseases.
Key Pearls
- Neuromuscular signs of alkalemia can be masked by sedation or neuromuscular blockers in critically ill patients.
- In lactic acidosis, a patient’s mental status may correlate better with the lactate level than with the pH alone.
2. Arterial Blood Gas Interpretation
A stepwise ABG approach—assessing pH first, then determining the primary respiratory (PaCO₂) versus metabolic (HCO₃⁻) disturbance—is crucial. This framework is based on the Henderson–Hasselbalch equation: pH = pKa + log([HCO₃⁻] / (0.03 × PaCO₂)).
Normal Laboratory Ranges
- pH: 7.35–7.45
- PaCO₂: 35–45 mm Hg
- HCO₃⁻: 22–26 mEq/L
Key Pearls
- A normal pH with abnormal PaCO₂ and HCO₃⁻ is a strong indicator of a mixed acid-base disturbance.
- Always verify sample integrity. Delayed analysis or storage at room temperature can falsely elevate PaCO₂ due to ongoing cellular metabolism.
3. Anion Gap and Delta-Ratio Analysis
The anion gap (AG) is used to identify the presence of unmeasured anions, while the delta ratio helps to unmask mixed metabolic acidoses.
Anion Gap (AG) Calculation
- Formula: AG = [Na⁺] – ([Cl⁻] + [HCO₃⁻])
- Normal Range: 8–12 mEq/L
- Albumin Correction: Since albumin is the primary unmeasured anion, the AG must be corrected for hypoalbuminemia. A common formula is: Corrected AG = Measured AG + 2.5 × (4.0 – measured albumin [g/dL]).
Delta Ratio
The delta ratio assesses the relationship between the increase in the anion gap (ΔAG) and the decrease in bicarbonate (ΔHCO₃⁻).
- Calculation: Δ Ratio = (AGmeasured – 12) / (24 – HCO₃⁻measured)
- Interpretation:
- 1 to 2: Suggests a pure high-AG metabolic acidosis (HAGMA).
- <1: Suggests a mixed HAGMA and normal-AG metabolic acidosis (NAGMA), as HCO₃⁻ has decreased more than the AG has increased.
- >2: Suggests a concurrent metabolic alkalosis, as HCO₃⁻ is higher than expected for the degree of AG elevation.
Key Pearls
- Always correct the anion gap for hypoalbuminemia in critically ill patients to avoid missing a HAGMA.
- Reference ranges for the anion gap can vary by laboratory. Confirm your institution’s normal values.
4. Compensatory Mechanisms and Expected Limits
Calculating the expected physiologic compensation is a critical step to distinguish simple acid-base disorders from more complex mixed disturbances. A mixed disorder is suspected whenever the actual measured values fall outside the predicted ranges.
| Primary Disorder | Expected Compensation Formula | Notes / Context |
|---|---|---|
| Metabolic Acidosis | Expected PaCO₂ = (1.5 × HCO₃⁻) + 8 ± 2 | Known as Winter’s formula. Compensation is rapid (respiratory). |
| Metabolic Alkalosis | Expected PaCO₂ ≈ 40 + (0.7 × [HCO₃⁻ – 24]) | Compensation (hypoventilation) is limited; PaCO₂ rarely exceeds 55 mm Hg. |
| Respiratory Acidosis | Acute: ↑HCO₃⁻ by 1 per 10 ↑PaCO₂ Chronic: ↑HCO₃⁻ by 3.5 per 10 ↑PaCO₂ |
Distinction between acute (<24h) and chronic (>72h) is key. Renal compensation is slow. |
| Respiratory Alkalosis | Acute: ↓HCO₃⁻ by 2 per 10 ↓PaCO₂ Chronic: ↓HCO₃⁻ by 5 per 10 ↓PaCO₂ |
Chronic compensation reflects sustained renal excretion of bicarbonate. |
Key Pearls
- Always perform manual compensation calculations. ABG analyzers report values but do not flag mixed disorders.
- Compensation formulas become less reliable at extreme pH values (e.g., pH < 7.10 or > 7.60).
5. Classification Systems and Severity Scores
Algorithms and severity metrics, such as base excess and the anion gap, help differentiate simple versus mixed disorders and inform the urgency of intervention.
Simple vs. Mixed Disorders
- Simple Disorder: Consists of one primary disturbance with the appropriate physiologic compensation.
- Mixed Disorder: Defined by the presence of more than one primary disorder. Compensation rules are violated.
Severity Thresholds and Metrics
- Base Excess (BE): A BE less than –5 mEq/L indicates significant metabolic acidosis, while a BE greater than +5 mEq/L indicates significant metabolic alkalosis.
- pH and Bicarbonate: A pH ≤7.20 or HCO₃⁻ ≤12 mEq/L is considered severe metabolic acidosis and warrants urgent attention.
- Anion Gap: An AG >16 mEq/L is an independent predictor of higher mortality in critically ill patients.
Risk Stratification
Clinical risk is best assessed by combining pH, base excess, anion gap, and evidence of end-organ dysfunction (e.g., acute kidney injury). These scores guide escalation of care, such as consideration for bicarbonate therapy or early renal replacement therapy (RRT).
Key Pearls
- Severe acidemia (pH ≤7.20) warrants rapid multidisciplinary evaluation involving critical care and nephrology.
- Mixed disorders, such as a high anion gap metabolic acidosis combined with respiratory acidosis (hypoventilation), carry the highest risk and require simultaneous management of both ventilation and metabolic derangements.
References
- Barletta JF, Muir J, Brown J, Dzierba A. A systematic approach to understanding acid–base disorders in the critically ill. Ann Pharmacother. 2024;58(1):65-75.
- Kraut JA, Madias NE. Serum anion gap: its uses and limitations in clinical medicine. Clin J Am Soc Nephrol. 2007;2(1):162-174.
- Wrenn K. The delta (Δ) gap: An approach to mixed acid-base disorders. Ann Emerg Med. 1990;19(11):1310-1313.
- Lewis JL 3rd. Acid-Base Disorders. Merck Manual Professional Version. Updated March 12, 2025.
- Jaber S, Paugam C, Futier E, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomized controlled trial. Lancet. 2018;392(10141):31-40.
- Achanti A, Sood MM, Waikar SS. Acid–Base Disorders in the Critically Ill Patient. Clin J Am Soc Nephrol. 2023;18(1):102-112.
- Dickerson RN. Fluids, Electrolytes, Acid-Base Disorders, and Nutrition Support. In: ACCP/SCCM Critical Care Pharmacy Preparatory Review. 2016.
